Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Aldeyra Therapeutics ( (ALDX) ).
Aldeyra Therapeutics, Inc. previously entered into a Loan and Security Agreement in March 2019 with Hercules Capital, Inc. and a syndicate of lenders, known as the Hercules Credit Facility, which had a scheduled maturity date of April 1, 2026. On April 1, 2026, Aldeyra fully repaid the remaining $15 million outstanding under this facility and terminated all related commitments, effectively ending the credit agreement.
The company has indicated that its cash, cash equivalents, and marketable securities as of December 31, 2025 are expected to support operations into 2028. The payoff of the Hercules Credit Facility and the projected cash runway suggest Aldeyra can continue operating without relying on this prior debt facility in the near term, which may reduce interest obligations and enhance financial flexibility for stakeholders.
The most recent analyst rating on (ALDX) stock is a Hold with a $2.00 price target. To see the full list of analyst forecasts on Aldeyra Therapeutics stock, see the ALDX Stock Forecast page.
Spark’s Take on ALDX Stock
According to Spark, TipRanks’ AI Analyst, ALDX is a Underperform.
The score is weighed down primarily by weak financial performance (no revenue, recurring losses, and renewed cash burn) and very bearish technicals (deep downtrend with negative momentum). A major negative catalyst—the second FDA Complete Response Letter—adds significant uncertainty around the lead program, while valuation signals remain constrained by losses and lack of dividend support.
To see Spark’s full report on ALDX stock, click here.
More about Aldeyra Therapeutics
Aldeyra Therapeutics, Inc. is a biotechnology company focused on developing therapies for immune-mediated and inflammatory diseases. The company funds its research and development activities through a combination of cash, cash equivalents, marketable securities, and prior access to credit facilities.
Average Trading Volume: 2,810,889
Technical Sentiment Signal: Sell
Current Market Cap: $101.7M
Find detailed analytics on ALDX stock on TipRanks’ Stock Analysis page.